<?xml version="1.0" encoding="UTF-8"?>
<p>At present, some compounds such as hydroquinone (HQ) (Patil et al., 
 <xref rid="fsn32004-bib-0034" ref-type="ref">2016</xref>), arbutin (Chang, 
 <xref rid="fsn32004-bib-0010" ref-type="ref">2009</xref>), kojic acid (Guo et al., 
 <xref rid="fsn32004-bib-0019" ref-type="ref">2018</xref>), azelaic acid (Sima et al., 
 <xref rid="fsn32004-bib-0039" ref-type="ref">2011</xref>), L‐ascorbic acid (Huang et al., 
 <xref rid="fsn32004-bib-0022" ref-type="ref">2013</xref>), ellagic acid (Zhu &amp; Gao, 
 <xref rid="fsn32004-bib-0051" ref-type="ref">2008</xref>), and tranexamic acid (Hsieh et al., 
 <xref rid="fsn32004-bib-0021" ref-type="ref">2013</xref>) have been identified to inhibit tyrosinase. However, HQ can cause skin irritation (Kim et al., 
 <xref rid="fsn32004-bib-0024" ref-type="ref">2017</xref>). Arbutin and kojic acid are highly cytotoxic and unstable in oxygen and water (Fujimoto et al., 
 <xref rid="fsn32004-bib-0018" ref-type="ref">1998</xref>). L‐Ascorbic acid is heat sensitive and easy to deteriorate (Spinola et al., 
 <xref rid="fsn32004-bib-0042" ref-type="ref">2013</xref>). Ellagic acid has poor bioavailability (Arulmozhi et al., 
 <xref rid="fsn32004-bib-0004" ref-type="ref">2013</xref>) and potential adverse interactions with taxane chemotherapy (Eskra et al., 
 <xref rid="fsn32004-bib-0014" ref-type="ref">2019</xref>). So it is of interest to identify and characterize novel tyrosinase inhibitors from plants.
</p>
